ticlopidine has been researched along with Animal Mammary Carcinoma in 2 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pandey, A | 1 |
| Sarangi, S | 1 |
| Chien, K | 1 |
| Sengupta, P | 1 |
| Papa, AL | 1 |
| Basu, S | 1 |
| Sengupta, S | 1 |
| Kim, JH | 1 |
| Park, HM | 1 |
2 other studies available for ticlopidine and Animal Mammary Carcinoma
| Article | Year |
|---|---|
Anti-platelet agents augment cisplatin nanoparticle cytotoxicity by enhancing tumor vasculature permeability and drug delivery.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cisplatin; Clopidogrel; D | 2014 |
Unilateral femoral arterial thrombosis in a dog with malignant mammary gland tumor: clinical and thermographic findings, and successful treatment with local intra-arterial administration of streptokinase.
Topics: Animals; Anticoagulants; Clopidogrel; Dog Diseases; Dogs; Female; Femoral Artery; Fibrinolytic Agent | 2012 |